2224 research outputs found
Sort by
Promoção da Qualidade das Relações Interpessoais, da Saúde e do Bem-Estar dos Enfermeiros do HFF: o Projeto, Resultados T1, e a Fase de Intervenção
Get PDFSystemic sclerosis-related changes on nailfold videocapillaroscopy in genetic and metabolic myopathies.
No full textinfo:eu-repo/semantics/publishedVersio
Internal quality control in histotechnology: a daily and cross-cutting method
No full textInternal quality control (IQC) is compulsory for laboratory certification and accreditation systems. On the subject of histotechnology, the discussion/dissemination of IQC tools would facilitate IQC implementation in routine laboratory practices, and would serve as a challenge to all professionals to develop a daily internal quality control tool in histotechnology (IQCH), cross-cutting grossing, histology, cytology, histochemistry, immunohistochemistry, and electron microscopy areas, in order to prematurely detect any deviations and, if possible, to rectify them immediately. In each laboratory area, verification steps were established (e.g. microtomy), through which deviations were identified and recorded (e.g. wrinkles/folds). In the final step, a cross-cutting classification scale is applied to samples, slides, and/or grids, according to specific area parameters and the potential interpretation impact of the recorded deviations. A qualitative/quantitative evaluation scale was obtained, which allows the classification of individual work units from Unsatisfactory/1' (presence of deviations that can influence or impede interpretation') to Very Good/5' (absence of deviations'). Any deviations observed are recorded based on a coded list. With regard to laboratory processes using samples/control tissues to validate the techniques that were conducted, an alphanumeric rating scale is applied, where the letter indicates the credibility level: from A' (max) to F' (zero).The continuous and constant use of this IQCH tool enables the identification of potential deviations and, possibly, their immediate correction. Classification of the various work units will allow the attainment of reference values that can be monitored and controlled, contributing to the improvement of individual and/or collective procedures, and promoting the involvement of every professional.info:eu-repo/semantics/publishedVersio
Central venous-to-arterial carbon dioxide difference and the effect of venous hyperoxia: A limiting factor, or an additional marker of severity in shock?
No full textCentral venous-to-arterial carbon dioxide difference (PcvaCO2) has demonstrated its prognostic value in critically ill patients suffering from shock, and current expert recommendations advocate for further resuscitation interventions when PcvaCO2 is elevated. PcvaCO2 combination with arterial-venous oxygen content difference (PcvaCO2/CavO2) seems to enhance its performance when assessing anaerobic metabolism. However, the fact that PCO2 values might be altered by changes in blood O2 content (the Haldane effect), has been presented as a limitation of PCO2-derived variables. The present study aimed at exploring the impact of hyperoxia on PcvaCO2 and PcvaCO2/CavO2 during the early phase of shock. Prospective interventional study. Ventilated patients suffering from shock within the first 24 h of ICU admission. Patients requiring FiO2 ≥ 0.5 were excluded. At inclusion, simultaneous arterial and central venous blood samples were collected. Patients underwent a hyperoxygenation test (5 min of FiO2 100%), and arterial and central venous blood samples were repeated. Oxygenation and CO2 variables were calculated at both time points. Twenty patients were studied. The main cause of shock was septic shock (70%). The hyperoxygenation trial increased oxygenation parameters in arterial and venous blood, whereas PCO2 only changed at the venous site. Resulting PcvaCO2 and PcvaCO2/CavO2 significantly increased [6.8 (4.9, 8.1) vs. 7.6 (6.7, 8.5) mmHg, p 0.001; and 1.9 (1.4, 2.2) vs. 2.3 (1.8, 3), p < 0.001, respectively]. Baseline PcvaCO2, PcvaCO2/CavO2 and ScvO2 correlated with the magnitude of PO2 augmentation at the venous site within the trial (ρ -0.46, p 0.04; ρ 0.6, p < 0.01; and ρ 0.7, p < 0.001, respectively). Increased PcvaCO2/CavO2 values were associated with higher mortality in our sample [1.46 (1.21, 1.89) survivors vs. 2.23 (1.86, 2.8) non-survivors, p < 0.01]. PcvaCO2 and PcvaCO2/CavO2 are influenced by oxygenation changes not related to flow. Elevated PcvaCO2 and PcvaCO2/CavO2 values might not only derive from cardiac output inadequacy, but also from venous hyperoxia. Elevated PcvaCO2/CavO2 values were associated with higher PO2 transmission to the venous compartment, suggesting higher shunting phenomena
High-risk features in potentially resectable colon cancer: a prospective MDCT-pathology agreement study
No full textNeoadjuvant chemotherapy in potentially resectable high-risk Stage II and Stage III colon cancer has demonstrated promising results in the PRODIGE 22-ECKINOXE Phase II trial. Identification of adverse morphologic features, namely T3 with >5 mm extramural extension/T4 stages and/or N2, is fundamental and requires accurate noninvasive imaging. Our aim was to assess the value of optimized preoperative MDCT to stratify potentially resectable colon cancer patients for neoadjuvant therapy.
METHODS:
this is an observational prospective cross-sectional radiologic-pathologic agreement study. All patients with colon cancer referred to our Institution's Radiology department for preoperative MDCT staging between 01-10-2013 and 11-02-2015 underwent independent reading based on axial and multiplanar reconstruction images by 3 radiologists with 3, 6, and 20 years of experience in gastrointestinal radiology. T stage, extramural extension if T3 (≤5 mm or >5 mm), and N stage were recorded. Surgical specimens subsequently obtained underwent micro-pathologic analysis by a gastrointestinal pathologist with 9 years of experience in gastrointestinal pathology. Main outcome measures were sensitivity, specificity, PPV, NPV, AUROC, diagnostic accuracy, and interobserver agreement of optimized MDCT, and pathologic analysis of the surgical specimen considered the reference standard.
RESULTS:
74 patients [43 males; median age 73 (45-89)] were eligible. MDCT sensitivity, specificity, PPV, NPV, AUROC, and diagnostic accuracy ranged between 42.9-76.2, 75.5-90.6, 55.2-76.2, 80.0-90.6, 0.67-0.83 and 0.76-0.86%, respectively, for the identification of T3 > 5 mm/T4 disease, with moderate interobserver agreement (0.49); and 8.3-33.3, 93.5-98.4, 20-66.7, 84.1-88.2, 0.51-0.65 and 0.80-0.86%, respectively, for the identification of N2 disease, with absent interobserver agreement (0.10).
CONCLUSIONS:
Specificity of MDCT in the stratification of patients for neoadjuvant therapy may be high enough to prevent overtreatment. However, it may lead to undertreatment in a meaningful proportion of patients. Observer performance may benefit from targeted training programs, given the variability and observer dependence of the results. Limitations include 4-slice MDCT equipment, time to surgery and lack of long-term outcome information based on imaging parameters per se
What is the Role of HbA1c in Diabetic Hemodialysis Patients?
No full textThe definition of a good glycemic control in patients with diabetes mellitus on hemodialysis is far from settled. In the general population, hemoglobin A1c is highly correlated with the average glycemia of the last 8-12 weeks. However, in hemodialysis patients, the correlation of hbA1c with glycemia is weaker as it also reflects changes in hemoglobin characteristics and red blood cells half-life. As expected, studies show that the association between HbA1c and outcomes in these patients differ from the general population. Therefore, the value of HbA1c in the treatment of hemodialysis patients has been questioned. Guidelines are generally cautious in their recommendations about possible targets of HbA1c in this population. Indeed, the risk of not treating hyperglycemia should be weighed against the particularly high risk of precipitating hypoglycemia in dialysis patients. In this review, a critical analysis of the current role of HbA1c in the care of hemodialysis patients is presented.info:eu-repo/semantics/publishedVersio
Validation of the Personal Wellbeing Index in People with Chronic Kidney Disease
Get PDFObjetivo: verificar las propiedades psicométricas del Índice de bien-estar personal (IBP) en personas con enfermedad renal crónica en programa de hemodiálisis.
Método: Se trata de un estudio metodológico. La muestra aleatoria es constituida por 171 personas con Enfermedad Renal Crónica (ERC) sometida a hemodiálisis en dos clínicas en la región de Lisboa, Portugal. La recogida de datos fue realizada entre mayo y junio de 2015. Se evaluaron las propiedades psicométricas: validad (constructo, predictiva convergente, y discriminativa), confiabilidad por medio de la consistencia interna (α de Cronbach) y estabilidad (Coeficiente de Correlación de Spearman-Brown y Coeficiente de Correlación Intraclasse (CCI)).
Resultados: El IBP presenta una dimensión ajustada a los datos. La satisfacción con la salud es lo que más contribuye para el IBP. Tiene validad convergente con Felicidad Subjetiva y Afecto Positivo y Afecto Negativo. Tiene poder discriminativo en la nacionalidad. El α Cronbach fue de 0,82. Teste Re-teste para cuestionario 0, 92 e CCI= 0,95, para entrevista 0,85 y CCI= 0,89.
Conclusiones: La versión portuguesa del IBP es válida y reproducible en personas con ERC, tanto por cuestionario como por entrevista.info:eu-repo/semantics/publishedVersio
Impact of bowel resection margins in node negative colon cancer.
Get PDFSurgical intestinal resection margins in colon cancer are a longstanding debate in terms the optimal distance between the tumor and the colonic section line. The aim of this study is to define the oncological outcomes in relation to surgical margins, measured in terms or recurrence rate, time-to-recurrence, disease-free survival and overall survival in a population of node negative colon cancer patients.
METHODS:
We conducted a retrospective observational longitudinal single institution study. All patients submitted to colon cancer surgery between January 2006 and December 2010 were analyzed. Only node negative patients were included in the study, with analysis of 215 patient charts, divided in two groups (Intestinal margin lower than 5 cm-group 1; and 5 cm or higher-group 2).
RESULTS:
Mean age of patients was 70.4 years (±11.7), with a male predominance (57.7%). Group 2 more frequently corresponded to Stage II (83 vs 71%; p = 0.05). Global mean total lymph nodes harvested were 12, and were higher in group II than in group I (13.8 ± 8.2 vs 10.4 ± 5.7; p = 0.001). In terms of time-to-recurrence patients of group 2 had longer time than patients of group 1 (32.3 ± 12.1 vs 21.8 ± 13.8 months; p = 0.03), as well as a lower recurrence rate in group I (13.7 vs 17.2%), despite not statistically significant.
CONCLUSIONS:
This study has showed that patients with 5 cm or higher bowel resection margins had longer time-to-recurrence that was statistically significant. Recurrence rates were lower in the group of patients with longer surgical margins, however not statistically significant.info:eu-repo/semantics/publishedVersio